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Introduction
Frailty is now a well-recognized and common syndrome 
among older persons (1-3). Frailty is a syndrome which 
increases the risk of an older person to develop disability or to 
die when exposed either to physical or psychosocial stressors 
(4, 5). Although frailty, disability and multimorbidity often 
coexist and interact, they are distinct and separate concepts 
(6). Growing evidence suggests that each of these interrelated 
conditions is preventable and their associated complications 
manageable (6-8). However, early identification is imperative 
as once disability and multimorbidity occur, frailty in less 
likely to be prevented or reversed (9-11). As such it should be 
distinguished from persons with disability in their activities 
of daily living. The conditions leading to the frailty syndrome 
should have some degree of reversibility, thus distinguishing 
it from multimorbidity (7, 8, 12). Recently, the International 
Conference of Frailty and Sarcopenia Research (ICFSR) 
formulated evidence-based guidelines for the identification 
and management of physical frailty (13). Physical frailty 
was originally defined and validated by Fried et al (12, 14). 
This definition included measurements of low activity level, 
slowness of walking, muscle weakness, exhaustion and 
weight loss. This approach differs from that of Rockwood and 
Mitnitski (15) which used the number of “deficits” (signs, 
symptoms, clinical conditions) to determine a frailty index. 
Primary care represents the entry point into the health care 
system for many older adults who may be pre-frail and frail. 
A shortage of geriatricians and the higher frequency of frailty 
in community settings call for primary care clinicians (general 
practitioners, generalists, family physicians) to increasingly 
assess and manage older adults at risk for frailty or who are 
already frail.
The purpose of this paper is to suggest practical frailty 
screening and management strategies in primary care settings. 
We will also discuss the characteristics of these instruments and 
their applicability to primary care. For the sake of consistency 
hereafter, we will refer to clinicians delivering primary care as 
primary care providers.
Screening (Case Finding)
Primary care providers around the world report high patient 
workloads. The average primary care physician spends between 
less than a minute on consultations in Bangladesh to over 20 
minutes in Sweden (16). Less than half of these physicians 
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spend more than 10 minutes for consultations. The short 
amount of time physicians spent with older persons makes it 
extremely difficult to identify and develop a comprehensive 
diagnostic and management plan for geriatric syndromes. 
Primary care providers need easy and rapid approaches to help 
them identify patients with frailty. Below we describe time-
efficient and validated screening tools that clinicians can use to 
identify frailty in older persons in primary care. 
The FRAIL scale (Figure 1) is a simple 5-item questionnaire 
that can be answered in 15 to 30 seconds (17, 18). In persons 
over 50 years of age the FRAIL Scale predicted disability 
and mortality at 9 years (19, 20). It performed as well as the 
Fried Frailty Phenotype (16a) and the Study of Osteoporosis 
Fractures (SOF). In the Australian Longitudinal Study on 
Women’s Health, the FRAIL scale predicted future disability 
over a 15-year period in middle aged women (21). A large 
study in Hong Kong demonstrated that FRAIL predicted over 4 
years both disability and mortality as well as the CHS scale and 
the Rockwood Frailty Index (22). FRAIL predicted mortality 
in the Survey of Health Aging and Retirement in Europe 
(SHARE) (23). Numerous other studies have validated the 
predictive capacity of FRAIL (24-28). Thus, the FRAIL scale 
is now recommended as a screen tool for older persons visiting 
primary care providers in Australia (29) and in Brazil (30). An 
adapted version of the tool has also been developed for nursing 
homes (i.e., FRAIL-NH), which has shown to be predictive of 
adverse outcomes in the long term care setting (31, 32). 
Another rapid screening test for frailty is the Clinical Frailty 
Scale (CFS) (33-35) . The CFS scale consists of 9 items and 
is available in a pictorial version with corresponding text. It is 
correlated with the Frailty Index and is predictive of mortality 
(33, 36). The first three items refer to persons that are non-
frail, item four assesses vulnerability whereas items five to 
eight include an assessment of disability. It is uncertain how 
correctly the average clinician can classify persons in the 
different categories (especially distinguishing  frail from the 
disabled) by using the Clinical Frailty Scale (CFS) and without 
falling into the risk of subjectivity. 
The Vulnerable Elders Survey-13 (VES-13) consists of 
questions to recognize older persons with frailty (37, 38). The 
VES-13 questionnaire consists of items measuring activities 
of daily living, physical function, self-rated health, and one 
question on age. It is a practical and brief screening tool that 
can be staff-administered or self-administered in less than 5 
minutes. It has been demonstrated to be a good predictor of 
decreased function and death in older persons (39, 40). 
The Kihon checklist was introduced by the Japanese long-
term care insurance system in 2006 as an evaluation of frailty 
(41, 42). It consists of 25 yes or no questions that evaluate 
the domains of physical function, nutrition, feeding, social 
activity, memory, mood and lifestyle (43). It has been validated 
against the Fried frailty phenotype (41). The Kihon checklist 
is predictive of mortality (44) and shows good diagnostic 
accuracy in identifying frailty in primary care based on a recent 
Australian study (45). 
The VES-13 (37, 38) and Kihon checklist (41, 42) include 
items assessing basic and instrumental activities of daily living 
among their scoring items. As with the Clinical Frailty Scale, 
clinicians using these instruments may have difficulties at 
distinguishing frailty from disability. 
The World Health Organization (WHO) has focused on 
developing an approach to screen persons for decreases in 
intrinsic capacity, defined as “the combination of the 
individual’s physical and mental, including psychological, 
capacities” (46). To screen for loss of intrinsic capacity 
they have developed the “Integrated Care for Older People” 
(ICOPE) instrument (47, 48). Primary care providers should 
match for frailty development due to physical inactivity 
during the COVID-19 pandemic (47). While not specifically 
designed to identify frailty and having no designated cutoff to 
distinguish frailty states, the screening test can be delivered by a 
professional screener or by patient self-assessment using either 
a mobile application (App) or the BOTFRAIL (an internet 
conversational robot). The ICOPE screening test consists 
of 6 areas including measurements of cognition, mobility, 
malnutrition, vision impairment, hearing loss and depression. 
(Table 1)
The Study of Osteoporotic Fractures (SOF) frailty scale was 
developed and validated in an all-female cohort. It consists 
of three items that are easy to administer: the ability to rise 
from an armless chair five times (inability = 1); response to 
the question “Do you feel full of energy?” (answer of “no” = 
1); and weight loss > 5% in the past year (presence of weight 
loss = 1). Each item is scored as 0 for normal or 1 for abnormal 
(Prefrail =1, and Frail = 2 or 3) (49)». The SOF can be easily 
incorporated into a primary care practice and is useful in 
the identification of patients who may require referral for 
comprehensive geriatric assessment. 
Frailty indexes that are automatically generated from 
electronic health records or administrative claims data may 
offer distinct advantages to busy primary care providers. As 
electronic health records become increasingly ubiquitous in 
primary care practices in high income countries, clinicians can 
use this information at the point of care to identify patients 
with frailty. Recently developed electronic frailty indexes 
have demonstrated predictive validity for hospitalizations, 
nursing home placement, cost of care,  prediction and resource 
allocation to care for populations in value-based care delivery 
(50-53). A limitation is that electronic health records may 
not yet be widely available in many low- and middle-income 
countries. Furthermore, they might rely on medical data of 
limited relevance for the older person, and ignore aspects of 
critical importance in geriatric patients (e.g., functional status).
Referral to Comprehensive Geriatric Assessment (CGA)
Investigators have often validated frailty screening 
instruments against the CGA (54). Screening instruments serve 
to identify those older adults who may be at risk for frailty or 
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Figure 1
The FRAIL and Other Components of the Rapid Geriatric Assessment
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may have already developed frailty. Although many frailty 
screening instruments are sensitive, these tools often display 
low specificity (55). Thus, screening tests require confirmation 
of frailty with more thorough evaluations of the older person 
such as those part of a CGA. Geriatric assessment may uncover 
previously unrecognized problems that may contribute to the 
development or progression of frailty in older adults (56-58). 
Timely identification of these problems may lead clinicians 
to design and implement personalized interventions which 
can improve patient outcomes (57, 58). At the same time, it is 
important to remind that the CGA is a process diagnostically 
and therapeutically. The assessments conducted in the first 
part of the CGA to identify the persons critical aspects should 
always be followed by a multi-disciplinary and integrated 
intervention to make the methodology meaningful.
Management of Frailty
There is a growing evidence in support of a variety of 
interventions that target older adults with frailty in primary care 
settings. Research indicates that exercise, nutrition and geriatric 
assessment represent effective, evidence-based interventions 
in primary care. A recent meta-analysis of 31 studies including 
4794 participants concluded that resistance exercise, with 
or without nutrition supplementation may improve the 
frailty status of older adults in primary care settings. In 
older subjects with diabetes and frailty, resistance exercise 
as part of a multimodal approach significantly improved 
physical performance over one year measured by the short 
performance physical battery (SPPB) which was accompanied 
by a significant decrease in healthcare expenditure (59). 
Table 2
Management of Frailty in Primary Care
Primary Prevention Secondary Prevention Tertiary Prevention
1. Provide community education including 
television, newspapers, magazines and social 
media to do aerobic and resistance exercise 
regularly
2. Health care professionals to regularly 
reinforce the importance of exercise.
3. Community lectures by health care 
professionals on the importance of exercise
4. Yearly screening with a rapid screen for 
frailty (FRAIL or ICOPE)
If positive frailty screen:
1. Check for and treat possible reversible 
causes as in Table 1 or 2
2. Enroll in an exercise program
3. Advise on adequate (leucine enriched) 
protein intake
4. Consider grip strength, 4m gait speed and 
short physical performance battery
1. Check ADLs and IADLs
2. Refer for comprehensive geriatric 
assessment
3. Refer to physical and occupational therapy
4. Optimize home environment
5. Provide a long term exercise program
Table 1
Screening Tool for the “Integrated Care for Older Persons” (ICOPE)
Priority Conditions Associated with Declines in 
Intrinsic Capacity
Tests
Cognitive Decline 1. Remember three words: Flower, door, rice (for example)
2. Orientation in time and space: What is the full date today? Where are you now (home, clinic, etc.)?
3. Recalls the three words?
Limited Mobility Chair rise test: Rise from chair five times without using arms. Did the person complete five chair rises 
within 14 seconds?
Malnutrition 1. Weight loss: Have you unintentionally lost more than 3 kg over the last three months?
2.  Appetite loss: Have you experienced loss of appetite?
Visual Impairment Do you have any problems with your eyes: Difficulties in seeing far, reading, eye diseases or current-
ly under medical treatment (e.g., diabetes, high blood pressure)?
Hearing Loss Hears whispers (whisper test) or Screening audiometry result is 35 dB or less or Passes automated 
app-based digits-in-noise test
Depressive Symptoms Over the past two weeks, have you been bothered by
• Feeling down, depressed or hopeless?
•  Little interest or pleasure in doing things?
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Comprehensive Geriatric Assessment was also more effective 
than control groups at reducing frailty (58). Older adults with 
frailty often display prolonged periods of sedentary behaviors 
(60). Interventions to reduce overall sedentary behavior in older 
people with frailty may include short bouts of physical activity 
after intervals of uninterrupted inactivity (13, 31). Although 
less studied, other clinical interventions such as nutrition 
may offer benefits to older adults with frailty in outpatient 
settings. Observational studies suggest potential benefits of the 
Mediterranean diet (61, 62) and of vitamin D supplementation 
in patients that are deficient (63, 64). A summary of these 
recommendations can be seen in Table 2.
The  following sections give an overview of two examples of 
management approaches implemented in primary care settings.
The Rapid Geriatric Assessment: A management program 
for the different components of the FRAIL has been developed 
at Saint Louis University and is being developed into an 
App (20, 22). For fatigue, common causes are depression, 
sleep apnea, hypotension, anemia, hypothyroidism, hypoxia 
and vitamin B12 deficiency (65). Persons who have trouble 
completing the resistance and aerobic questions can be referred 
to multicomponent exercise program for sarcopenia (49, 66). 
They may also benefit from a leucine enriched essential amino 
acid supplement (67). Persons with more than five illnesses 
should have their medications reviewed to see if they are 
on inappropriate medications for older persons or if they 
have polypharmacy, where reduction of some medicines may 
improve their function (68-71). Older persons with weight 
loss should be examined for treatable causes of weight loss 
as delineated by the MEALS-ON-WHEELS mnemonic (8). 
In addition, the use of a caloric supplement can be considered 
(72) (Table 3). The FRAIL screen has been integrated 
with 3 other tests: The SARC-F (Sarcopenia) (2, 73), the 
Simplified Nutrition Appetite Questionnaire (SNAQ) (74, 
75) and the  Rapid Cognitive Screen (RCS) (76) to provide 
a more comprehensive geriatric examination, which can be 
performed by a primary care provider or other allied health care 
professionals (Figure 1). The complete RGA can be carried out 
in under 5 minutes (77) and is available as an App which was 
utilized by the National University Health System in Singapore 
(78). Furthermore, the RGA can be integrated into the Medicare 
Annual Wellness Visit (79).
Table 3
Diagnostic and Management Program for an Older Individual who has Deficits on the FRAIL Questionnaire (Copyright Saint 




Measure TSH, Vitamin B12 and Hemoglobin
Exclude low blood pressure or orthostasis resistance or Aerobic: Aerobic and Resistance exercise
Leucine enriched essential amino acid supplement
Measure bioavailable vitamin D and replace if low
Illnesses: Remove inappropriate medications including those causing side effects
Reduce Polypharmacy
Loss of Weight: Exclude depression
Stop drugs causing weight loss
Check for elderly abuse
Is the person paranoic (late life paranoia) or afraid being overweight will kill them?
Does the person have dysphagia?
Are there oral problems making chewing difficult?
Does the person have a nosocomial infection, e.g., Helicobacter pylori or tuberculosis?
Does the person have dementia?
Does the person have hyperthyroidism, Addison’s disease or pheochromocytoma?
Does the person have celiac disease or pancreatic insufficiency?
Does the person have eating difficulties?
Is person on low salt, low cholesterol or other therapeutic diet?
Does the person have cholecystitis?
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The Integrated Care for Older People: The ICOPE program 
may be indicated for older persons that are either pre-frail 
or frail. The ICOPE rationale to target older persons at the 
pre-frail stage is that early interventions aimed at reversing 
pre-frailty or preventing the patient from becoming frail are 
more likely to be successful. It may also reduce the need to 
implement a higher number of step by step approaches which 
may be more suited to older persons who are already frail.  In 
the ICOPE program, the older person is referred to either a 
primary care provider or a trained nurse to complete a geriatric 
assessment that includes a personalized intervention plan which 
is reassessed every 4 months. The follow up reassessments 
can be performed remotely through telemedicine (80). Each 
time the team detects a worsening of one or more ICOPE 
functions, they proceed to evaluate the reasons for the deficit 
(step 2 ICOPE) and propose personalized interventions (step 
3). The  ICOPE program encompasses medical, environmental 
and  social domains. Moreover, older persons participation 
and empowerment are integral parts of the ICOPE program. 
Older persons learn how to self-assess their ICOPE functions 
using self-managements tools, apps or conversational bots 
(automated computer programs that interact with humans) (80). 
Digital medicine, e-health and telemedicine technologies offer 
healthcare teams efficient ways to monitor ICOPE functions 
and intervene in a timely fashion when indicated. For example, 
as part of the INSPIRE program a nurse monitors older persons’ 
functional status by reviewing databases every 4 months. If 
new abnormalities are detected, the nurse refers the older 
person to the primary care provider for step 2. The primary 
care provider can then choose to implement step 2 part during a 
routine clinical encounter, ask a trained nurse to perform a more 
comprehensive geriatric assessment, or contact a geriatrician for 
a tele-expertise  consultation. The primary care provider uses 
the results of the cognitive and frailty scales to decide whether 
it is appropriate to refer the patient to a geriatrician (48, 80, 81). 
Another possible approach is to utilize the Korean Frailty Index 
for primary Care (82).
Frailty within a Primary Care Model of Care
The optimal management of an older person with frailty in 
primary care requires a coordinated and integrated approach. 
Primary care providers need to work in collaboration with 
multidisciplinary teams which involve geriatricians, allied 
health professionals (including physiotherapists, dieticians, 
exercise physiologists, social workers, and occupational 
therapists), caregivers and the patient themselves. A model of 
care that is widely adopted in the US is the patient-centered 
medical home model (PCMH) (83). The principles that guide 
this model are relevant to the care of older adults with frailty 
ensuring the delivery of comprehensive care, that is patient-
centered, coordinated, accessible, safe and of high quality (84, 
85). The PCMH model may provide an organizing framework 
for the implementation of screening and management strategies 
by primary care providers (86, 87). Within this model, 
primary care providers lead a team of professionals to ensure 
comprehensive and coordinated care for older adults with 
frailty. 
The Role of Education and Training
Key to the success of frailty screening and management 
initiatives in primary care is participation of competent 
and motivated primary care providers (88). Education and 
training of the workforce represent crucial approaches to 
increase the uptake of screening and management for frailty 
in primary care (89).  Success of these initiatives will demand 
that undergraduate, graduate and continuing professional 
development training programs for medical and allied health 
practitioners include these topics in their curricula.  
Conclusion
A number of rapid screening tests have been developed 
to evaluate frailty in the older population. These tests are 
predictive of poor clinical outcomes. Screening and managing 
frailty appear to be reasonable approaches to reducing disability 
in older persons. It is important to adapt our health care system 
to the aging of the population and move from the traditional 
disease-oriented medical model to a more global and modern 
patient-centered model that encompasses the assessment, 
monitoring and maintenance of function with the ultimate goal 
of preventing frailty and disability.
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